Friday, 28 June 2019

Pfizer's Avastin biosimilar wins FDA approval

Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)